Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [ATAC-seq]

ABSTRACT: Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [ATAC-seq]

PROVIDER: PRJNA807922 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18057200_1.fastq.gz	Fastqsanger.gz
	SRR18057200_2.fastq.gz	Fastqsanger.gz
	SRR18057201_1.fastq.gz	Fastqsanger.gz
	SRR18057201_2.fastq.gz	Fastqsanger.gz
	SRR18057202_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 56

Similar Datasets

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver

Project description:Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver

| PRJNA807918 | ENA

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [RNA-seq]

Project description:Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [RNA-seq]

| PRJNA807925 | ENA

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [ChIP-seq]

Project description:Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [ChIP-seq]

| PRJNA807926 | ENA

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [ATAC-seq]

Project description:Most common genetic variants associated with disease are located in non-coding regions of the genome. One mechanism by which they function is through altering transcription factor (TF) binding. In this study, we explore how genetic variation is connected to differences in the regulatory landscape of livers from C57BL/6J and 129S1/SvImJ mice fed either chow or a high-fat diet. To identify sites where regulatory variation affects TF binding and nearby gene expression, we employed an integrative analysis of H3K27ac ChIP-seq (active enhancers), ATAC-seq (chromatin accessibility) and RNA-seq (gene expression). We show that, across all these assays, the genetically driven (i.e. strain-specific) differences in the regulatory landscape are more pronounced than those modified by diet. Most notably, our analysis revealed that differentially accessible regions (DARs, N = 29635, FDR < 0.01 and fold change > 50%) are almost always strain-specific and enriched with genetic variation. Moreover, proximal DARs are highly correlated with differentially expressed genes. We also show that TF binding is affected by genetic variation, which we validate experimentally using ChIP-seq for TCF7L2 and CTCF. This study provides detailed insights into how non-coding genetic variation alters the gene regulatory landscape, and demonstrates how this can be used to study the regulatory variation influencing TF binding.

2023-12-11 | GSE196939 | GEO

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [RNA-seq]

2023-12-11 | GSE196941 | GEO

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver [ChIP-seq]

2023-12-11 | GSE196940 | GEO

Genetic determinants of TCF7L2 binding and chromatin availability in mouse liver

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-12-11 | GSE196942 | GEO

Identification TCF7L2 RNA binding proteins by LC-MS

Project description:Identification of TCF7L2 RNA binding proteins by LC/MS

2025-01-13 | PXD048312 | Pride

Identification TCF7L2-L, tcf7l2-S and IgG COIP proteins by LC-MS

Project description:Identification of binding protein of TCF7L2-L by LC/MS

2025-01-13 | PXD048102 | Pride

Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3

Project description:The TCF7L2 transcription factor is linked to a variety of human diseases, including type 2 diabetes and cancer. One mechanism by which TCF7L2 could influence expression of genes involved in diverse diseases is by binding to distinct regulatory regions in different tissues. To test this hypothesis, we performed ChIP-seq for TCF7L2 in 6 human cell lines. We identified 116,000 non-redundant TCF7L2 binding sites, with only 1,864 sites common to the 6 cell lines. Using ChIP-seq, we showed that many genomic regions that are marked by both H3K4me1 and H3K27Ac are also bound by TCF7L2, suggesting that TCF7L2 plays a critical role in enhancer activity. Bioinformatic analysis of the cell type-specific TCF7L2 binding sites revealed enrichment for multiple transcription factors, including HNF4alpha and FOXA2 motifs in HepG2 cells and the GATA3 motif in MCF7 cells. ChIP-seq analysis revealed that TCF7L2 co-localizes with HNF4alpha and FOXA2 in HepG2 cells and with GATA3 in MCF7 cells. Interestingly, in MCF7 cells the TCF7L2 motif is enriched in most TCF7L2 sites but is not enriched in the sites bound by both GATA3 and TCF7L2. This analysis suggested that GATA3 might tether TCF7L2 to the genome at these sites. To test this hypothesis, we depleted GATA3 in MCF7 cells and showed that TCF7L2 binding was lost at a subset of sites. RNA-seq analysis suggested that TCF7L2 represses transcription when tethered to the genome via GATA3. Our studies demonstrate a novel relationship between GATA3 and TCF7L2, and reveal important insights into TCF7L2-mediated gene regulation.

2012-06-05 | GSE38447 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data